480 related articles for article (PubMed ID: 12116054)
1. Evolving concepts of management of febrile neutropenia in children with cancer.
Orudjev E; Lange BJ
Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
[TBL] [Abstract][Full Text] [Related]
2. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
3. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
4. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
6. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
[TBL] [Abstract][Full Text] [Related]
7. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
9. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
[TBL] [Abstract][Full Text] [Related]
10. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
Boragina M; Patel H; Reiter S; Dougherty G
Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314
[TBL] [Abstract][Full Text] [Related]
11. Approach to treatment of the febrile cancer patient with low-risk neutropenia.
Buchanan GR
Hematol Oncol Clin North Am; 1993 Oct; 7(5):919-35. PubMed ID: 8226566
[TBL] [Abstract][Full Text] [Related]
12. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
Carstensen M; Sørensen JB
J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
[TBL] [Abstract][Full Text] [Related]
13. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
14. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
15. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
16. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
Santolaya ME
Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial therapy of febrile neutropenia--current developments].
Karthaus M; Cornely OA; Südhoff T; Meran J
Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
[TBL] [Abstract][Full Text] [Related]
18. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Aquino VM; Herrera L; Sandler ES; Buchanan GR
Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]